Literature DB >> 9801989

Hexarelin, a synthetic GH-releasing peptide, is a powerful stimulus of GH secretion in pubertal children and in adults but not in prepubertal children and in elderly subjects.

J Bellone1, E Bartolotta, C Sgattoni, G Aimaretti, E Arvat, S Bellone, R Deghenghi, E Ghigo.   

Abstract

GH-releasing peptides (GHRPs) and their non-peptidly mimetics are synthetic molecules which possess marked, dose-related and reproducible GH-releasing effect even after oral administration. Their potent stimulatory effect on GH secretion suggested that GHRP could be useful as provocative test on the diagnosis of GH deficiency. We compared the GH response to the maximal effective dose of Hexarelin (2 micrograms/kg i.v.), an hexapeptide belonging to GHRP family, with that of GHRH (1 microgram/kg i.v.) alone and combined with arginine (ARG, 0.5 g/kg i.v.), which likely acts via inhibition of hypothalamic somatostatin release. We studied 6 prepubertal (4 boys and 2 girls, age 2.6-12.2 yr) and 6 pubertal children with normal short stature (3 boys and 3 girls, age 10.3-14.4 yr) as well as 12 normal young adults (6 males and 6 females, age 22-30 yr) and 12 normal elderly subjects (6 males and 6 females, age 53-79 yr). In prepubertal children, the GH response to HEX (19.0 +/- 4.6 micrograms/l; 611.5 +/- 121.4 micrograms/l/h) was lower than that to GHRH (27.4 +/- 12.7 micrograms/l; 1209.0 +/- 590.9 micrograms/l/h) but this difference did not attain statistical significance. Both these responses were, in turn, lower (p < 0.05) than that to ARG + GHRH (57.9 +/- 15.1 micrograms/l; 2483.6 +/- 696.6 micrograms/l/h). In pubertal children, the GH response to HEX (67.6 +/- 12.7 micrograms/l; 2755.3 +/- 547.3 micrograms/l/h) was higher than that to ARG + GHRH (49.1 +/- 8.9 micrograms/l; 2554.1 +/- 356.6 micrograms/l/h) but this difference did not attain statistical significance; both these responses were, in turn, clearly higher (p < 0.05) than that to GHRH alone (23.1 +/- 7.9 micrograms/l; 1004.8 +/- 214.3 micrograms/l/h). In young adults, the GH response to HEX 60.9 +/- 8.0 micrograms/l; 2401.0 +/- 376.2 micrograms/l/h) was similar to that to ARG + GHRH (68.9 +/- 11.7 micrograms/l; 3035.7 +/- 466.6 micrograms/l/h) and both were clearly higher (p < 0.001) than that to GHRH alone (21.6 +/- 3.6 micrograms/l; 790.0 +/- 137.0 micrograms/l/h). In elderly subjects, the GH response to HEX (22.4 +/- 4.9; 855.0 +/- 199.0 micrograms/l/h) was higher (p < 0.01) than that to GHRH (3.6 +/- 0.8 micrograms/l; 151.8 +/- 24.6 micrograms/l/h) but lower (p < 0.05) than that to ARG + GHRH (48.1 +/- 4.6 micrograms/l; 1758.2 +/- 149.1 micrograms/l/h). In conclusion, GHRPs are a powerful stimulus of GH secretion in pubertal children and young adults only. On the other hand, the age-related variations in the GH response to GHRPs probably limit their reliability for the evaluation of GH releasable pool in prepubertal children and elderly subjects.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9801989     DOI: 10.1007/BF03347334

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN: 0391-4097            Impact factor:   4.256


  43 in total

1.  Comparison between insulin-induced hypoglycemia and growth hormone (GH)-releasing hormone + arginine as provocative tests for the diagnosis of GH deficiency in adults.

Authors:  G Aimaretti; G Corneli; P Razzore; S Bellone; C Baffoni; E Arvat; F Camanni; E Ghigo
Journal:  J Clin Endocrinol Metab       Date:  1998-05       Impact factor: 5.958

2.  Oestrogen replacement does not restore the reduced GH-releasing activity of Hexarelin, a synthetic hexapeptide, in post-menopausal women.

Authors:  E Arvat; L Gianotti; F Broglio; B Maccagno; A Bertagna; R Deghenghi; F Camanni; E Ghigo
Journal:  Eur J Endocrinol       Date:  1997-05       Impact factor: 6.664

3.  A new test for the diagnosis of growth hormone deficiency due to primary pituitary impairment: combined administration of pyridostigmine and growth hormone-releasing hormone.

Authors:  E Ghigo; E Imperiale; G M Boffano; E Mazza; J Bellone; E Arvat; M Procopio; S Goffi; A Barreca; P Chiabotto
Journal:  J Endocrinol Invest       Date:  1990-04       Impact factor: 4.256

Review 4.  Clinical aspects of growth hormone deficiency in adults.

Authors:  H de Boer; G J Blok; E A Van der Veen
Journal:  Endocr Rev       Date:  1995-02       Impact factor: 19.871

5.  The growth hormone response to hexarelin in children: reproducibility and effect of sex steroids.

Authors:  S Loche; A Colao; M Cappa; J Bellone; G Aimaretti; G Farello; A Faedda; G Lombardi; R Deghenghi; E Ghigo
Journal:  J Clin Endocrinol Metab       Date:  1997-03       Impact factor: 5.958

6.  Neuroendocrine responses to a novel growth hormone secretagogue, L-692,429, in healthy older subjects.

Authors:  J A Aloi; B J Gertz; M L Hartman; W C Huhn; S S Pezzoli; J M Wittreich; D A Krupa; M O Thorner
Journal:  J Clin Endocrinol Metab       Date:  1994-10       Impact factor: 5.958

7.  Growth hormone-releasing activity of hexarelin, a new synthetic hexapeptide, before and during puberty.

Authors:  J Bellone; G Aimaretti; E Bartolotta; L Benso; B P Imbimbo; V Lenhaerts; R Deghenghi; F Camanni; E Ghigo
Journal:  J Clin Endocrinol Metab       Date:  1995-04       Impact factor: 5.958

Review 8.  Growth hormone secretagogues. Clinical experience and therapeutic potential.

Authors:  Z Laron
Journal:  Drugs       Date:  1995-10       Impact factor: 9.546

9.  Growth hormone (GH) responses to the combined administration of GH-releasing hormone plus GH-releasing peptide 6 in adults with GH deficiency.

Authors:  A Leal-Cerro; E Garcia; R Astorga; F F Casanueva; C Dieguez
Journal:  Eur J Endocrinol       Date:  1995-06       Impact factor: 6.664

10.  Plasma growth hormone response to growth hormone-releasing hexapeptide (GH-RP-6) in children with short stature.

Authors:  M Pombo; J Barreiro; A Peñalva; F Mallo; F F Casanueva; C Dieguez
Journal:  Acta Paediatr       Date:  1995-08       Impact factor: 2.299

View more
  2 in total

1.  Integrating GHS into the Ghrelin System.

Authors:  Johannes D Veldhuis; Cyril Y Bowers
Journal:  Int J Pept       Date:  2010-03-18

2.  Sex steroids, GHRH, somatostatin, IGF-I, and IGFBP-1 modulate ghrelin's dose-dependent drive of pulsatile GH secretion in healthy older men.

Authors:  Johannes D Veldhuis; Catalina Norman; John M Miles; Cyril Y Bowers
Journal:  J Clin Endocrinol Metab       Date:  2012-09-18       Impact factor: 5.958

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.